Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DuoStim vs. Conventional Ovarian Stimulation for PGT
NCT03291821Phase 4Completed
- Sponsor
- International Vaccine Institute
- Start
- Dec 2017
- Primary completion
- Dec 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of human menopausal gonadotrophin in female infertility, sponsored by International Vaccine Institute. Primary endpoint: Rate of euploid embryos per cycle at 9 months. Started Dec 2017; status: completed.
02
Drugs
human menopausal gonadotrophin
03
Conditions
female infertility
Beyond the preview
Go deeper on NCT03291821.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03291821.